SpecStream

Data / Form D filings / FibroBiologics, Inc.

FibroBiologics, Inc.: Form D filing

FibroBiologics, Inc., a pharmaceuticals company in Houston, TX, filed a Form D with the SEC in 2026. The latest, on October 13, 2026, reports $1.2 million sold of a $1.2 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Get filings like this oneWeekly RSS feed

Company details from the filing

Address
9350 KIRBY DRIVE SUITE 300, Houston, TX, 77054
Phone
(281) 671-5150
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2021
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1958777

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 13New notice$1,200,000$1,200,0001Oct 7sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Pete O'HeeronExecutive Officer, DirectorChief Executive Officer
Richard C. CilentoDirector
Robert HoffmanDirector
Victoria NiklasDirector
Kathleen H. RubinsDirector
Leigh SteinbergDirector
Jason D. DavisExecutive OfficerChief Financial Officer
Ruben A. GarciaExecutive OfficerGeneral Counsel
Hamid KhojaExecutive OfficerChief Scientific Officer

Other pharmaceuticals companies in Texas that filed recently

Every Form D from the week of Oct 12 · All recent filings in Texas · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what FibroBiologics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.